7 results
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Evaluation and ... Cell Crises Clinical ... #Diagnosis #Management ... #Hematology #SickleCell ... #Ddxof
The 6 C’s of Primary Sclerosing Cholangitis (PSC)
PSC is a chronic, cholestatic, immune-mediated disease characterized by
are male and the median ... asymptomatic at diagnosis ... disease management ... clinical trial evaluation ... #Hepatology
Common Variable Immunodeficiency (CVID)

What?
CVID: Immunodeficiency disorder with hypogammaglobulinemia -> increased infection risk secondary to impaired B-cell
to impaired B-cell ... disease • Liver ... Lymphoma or other cancers ... autoimmune hemolytic anemia ... #diagnosis #management
Solitary Cell Plasmacytoma

What?
• Plasma cell neoplasms can present as a single lesion (solitary plasmacytoma)
• In 3%
Median age 50- ... common - GI tract, liver ... • No CRAB - no anemia ... Evaluation? ... Prognosis: • Median
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
recognition and management ... it is often a cancer ... - Cytopenias (anemia ... - Elevated liver ... #Management #Hematology
Elevated Globulin - Protein Gap (Total Protein - Albumin > 4)

Work-up of an Elevated Globulin Gap:
•
first step in evaluation ... Sarcoidosis) • Liver ... ovarian tumors, lung cancers ... anemia • Other ... #differential #diagnosis
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
Because the median ... age at diagnosis ... disease tolerate anemia ... with repeated red cell ... #algorithm #hematology